Mylan launches generic Yasmin

HERTFORDSHIRE, England and Pittsburgh — Mylan on Tuesday announced the launch of its generic version of Bayer’s Yasmin (drospirenone and ethinyl estradiol) birth control tablets.

The branded version of the 3-mg tablets had U.S. sales of about $137.6 million for the 12 months ended June 30, according to IMS Health. This is Mylan’s 13th U.S. oral contraceptive product.